Skip to content

Clinical trials

Macular Degeneration trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Country / region: Singapore Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20111
20132
20151
20171
20211
20221
20231
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Unknown status2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Singapore National Eye Centre4
Tan Tock Seng Hospital4
Novartis Pharmaceuticals2
4D Molecular Therapeutics1
Allergan1
Bayer1
National University of Singapore1
Novartis1
Shanghai Henlius Biotech1
Singapore Eye Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration17
Polypoidal Choroidal Vasculopathy3
Diabetic Retinopathy2
Glaucoma2
Blindness1
Choroidal Neovascularization1
Chronic Disease1
Eye Diseases1
Myopia1
Polyps1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.